Glipizide
CAS 29094-61-9 21 FDA-DMF suppliersSmall Molecule
Overview
Glipizide is a second-generation sulfonylurea used to control blood sugar levels in patients with type 2 diabetes. It functions by stimulating the release of insulin from the beta cells of the pancreas.
API suppliers (25)
Suppliers of Glipizide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- AMSA SPA1 active DMF
- USV PRIVATE LTD1 active DMF
- FERMION OYFinland1 active DMF
- AMSA SPA1 active DMF
- PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC1 active DMF
- FERMION OYFinland1 active DMF
- URQUIMA SA1 active DMF
- USV PRIVATE LTD1 active DMF
- AMSA SPA1 active DMF
- SRI KRISHNA PHARMACEUTICALS LTDIndia1 active DMF
- TAIZHOU HISOUND PHARMACEUTICAL CO LTDChina1 active DMF
- CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
- OLON SPAItaly1 active DMF
- URQUIMA SA1 active DMF
- TAIZHOU HISOUND PHARMACEUTICAL CO LTDChina1 active DMF
- FERMION OYFinland1 active DMF
- FERMION OYFinland1 active DMF
- AMSA SPA1 active DMF
- TAIZHOU HISOUND PHARMACEUTICAL CO LTDChina1 active DMF
- SUMITOMO CHEMICAL CO LTDJapan
- PROSTINEX
- Abbott LaboratoriesUSA
- CHINA CHEMICAL SYNTHESIS INDUSTRIAL CO LTD
- Lupin LimitedIndia
- FINE CHEMICALS CORP PTY LTD
Therapeutic areas
EndocrinologyDiabetes Care
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.